Clinical trial results presented at the Vascular Interventional Advances (VIVA) 2019 conference in Las Vegas and the American Heart Association (AHA) conference in Philadelphia dominated Medtech Insight’s list of most-read medical device research and development articles in November.
Results from the 32-patient PROMISE I trial presented at VIVA showed LimFlow's percutaneous deep vein arterialization system improves outcomes in patients with critical limb ischemia with no other...